Premier Health of America Inc.
Premier Health of America Inc. (PHA.V) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
pha.v · pe ratio · data through Sep 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Premier Health of America Inc. (PHA.V) measures how much investors pay for each dollar of the company's trailing earnings. PHA.V's current PE ratio of N/A is calculated by dividing its stock price of $0.02 by its TTM earnings per share of -$0.28.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-09-30
PE Ratio History
2017 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 3 fiscal years · Front-end computedMinQ1 · 25%36.5x
MedianQ3 · 75%859.0x
Max
At N/A, PHA.V's current P/E is lower than in 0% of its annual fiscal year readings over the past 3 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Premier Health of America Inc.You PHA.V | $1M | N/A | — | -$0.28 |
 Captor Capital Corp. CPTR.CN | $1M | 0.28x | — | $2.21 |
 Copland Road Capital Corporation CRCC.CN | $1M | N/A | — | -$0.05 |
 Entheon Biomedical Corp. ENBI.CN | $1M | N/A | — | -$0.02 |
 Universal Ibogaine Inc. IBO.V | $2M | N/A | — | -$0.06 |
 Doseology Sciences Inc. MOOD.CN | $1M | N/A | — | -$0.10 |
 Ovation Science Inc. OVAT.CN | $0M | N/A | — | -$0.02 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-09-30Latest FY2025 | — | $-0.28 | — | |
2024-09-30 FY2024 | — | $-0.23 | — | |
2023-09-30 FY2023 | — | $-0.03 | — | |
2022-09-30 FY2022 | — | $-0.00 | — | |
2021-09-30 FY2021 | 36.49x | $0.03 | -95.8% | |
2020-09-30 FY2020 | 858.97x | $0.00 | — | |
2019-09-30 FY2019 | — | $-0.01 | — | |
2018-09-30 FY2018 | — | $-0.00 | — | |
2017-09-30 FY2017 | 5.13x | $0.04 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Premier Health of America Inc. (PHA.V) measures how much investors pay for each dollar of the company's trailing earnings. PHA.V's current PE ratio of N/A is calculated by dividing its stock price of $0.02 by its TTM earnings per share of -$0.28.
Frequently asked questions
PHA.V pe ratio · 6 questionsPHA.V's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.02 and TTM EPS of -$0.28. Data sourced from Financial Modeling Prep via PHA.V's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Premier Health of America Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09